FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Sodium Chloride 0.9% Injection
Status: Discontinuation
»Therapeutic Categories: Gastroenterology; Other; Renal

Expand all

Hospira, Inc., a Pfizer Company (New 12/03/2025)

Company Contact Information:
844-646-4398

Presentation	Posting Date	Related Information
Sodium Chloride 0.9%, Injection, 250 mL ADD-Vantage® Flexible Container (NDC 0409-7101-02)	12/03/2025	Discontinuation of the manufacture of the drug
Sodium Chloride 0.9%, Injection, 50 mL ADD-Vantage® Flexible Container (NDC 0409-7101-66)	12/03/2025	Discontinuation of the manufacture of the drug
Sodium Chloride 0.9%, Injection, 100 mL ADD-Vantage® Flexible Container (NDC 0409-7101-67)	12/03/2025	Discontinuation of the manufacture of the drug